ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

304
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
13 Jul 2017 11:26

Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics

Celltrion Healthcare (091990 KS) (CH) is raising US$701 - 884m in its upcoming IPO. Proceeds raised will be used to fund general working capital,...

Share
12 Jul 2017 13:51

Celltrion Healthcare IPO Part 4 - Valuation & Pricing Debate

Celltrion Healthcare (091990 KS)'s bookbuilding is now in progress among overseas investors, and local bookbuilding will begin tomorrow and end on...

Logo
274 Views
Share
08 Jul 2017 14:54

The Week That Was in NorthAsia@Smartkarma: N. Korea Escalation, Idemitsu Feud and Korea Holdcos

This week Prasenjit K. Basu incites discussion into the policies of the Trump administration centring on recent developments on the Korean...

Logo
Mio Kato
195 Views
Share
03 Jul 2017 11:54

Celltrion Healthcare IPO Part 3 - What Local Institutions Seem to Have in Mind

Celltrion Healthcare (091990 KS) officials are currently meeting Korea's local institutional investors for its IPO. Local roadshow began on June...

Logo
279 Views
Share
11 Jun 2017 22:12

Samsung Electronics May Reverse Treasury Share Cancellation Decision

I think it is really time to talk more candidly about Samsung's restructuring problems. In the last 4 weeks (since May 8 to last Friday). C&T...

Logo
256 Views
Share
x